Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study

American Journal of Hematology

Volumn 85, Issue 2, 2010, Pages 101-105

  McLaren, Christine E ^a   Barton, James C ^b   Eckfeldt, John H ^c   McLaren, Gordon D ^d,e   Acton, Ronald T ^f   Adams, Paul C ^g   Henkin, Leora F ^h   Gordeuk, Victor R ⁱ   Vulpe, Chris D ^j   Harris, Emily L ^k   Harrison, Barbara W ^l   Reiss, Jacob A ^m   Snively, Beverly M ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SOUTHERN IRON DISORDERS CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f University of Alabama at Birmingham   (United States)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^l HOWARD UNIVERSITY   (United States)

^m NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AMPLIFIER; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; ETHNICITY; FAMILY STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENETIC VARIABILITY; GENOTYPE; HEMOCHROMATOSIS; HERITABILITY; HISPANIC; HOMOZYGOSITY; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; PRIORITY JOURNAL; RACE; REFERENCE VALUE; SCREENING;

ADULT; AGED; FAMILY; FEMALE; FERRITINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE;

EID: 75449090777     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21585     Document Type: Article

References (38)

1. Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-1362.
2. Motulsky AG, Beutler E. Population screening in hereditary hemochromatosis. Annu Rev Public Health 2000;21:65-79.
3. Barton JC, McDonnell SM, Adams PC, et al.Hemochromatosis Management Working Group. Management of hemochromatosis. Ann Intern Med 1998;129:932-939.
4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
5. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95:1472-1477.
6. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997;61:762-764.
7. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
8. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, et al. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-198.
9. Pietrangelo A. Hereditary hemochromatosis - A new look at an old disease. N Engl J Med 2004;350:2383-2397.
10. Bothwell T, Charlton R, Cook J, et al. Iron Metabolism in Man. Oxford: Blackwell Scientific Publications; 1979.
11. Whitfield JB, Treloar S, Zhu G, et al. Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Haematol 2003;120:860-866.
12. Zacharski LR, Ornstein DL, Woloshin S, et al. Association of age, sex, and race with body iron stores in adults: Analysis of NHANES III data. Am Heart J 2000;140:98-104.
13. Beutler E. Penetrance of haemochromatosis. Gut 2003;52:610-611.
14. Visscher PM, Hill WG, Wray NR. Heritability in the genomics era - Concepts and misconceptions. Nat Rev Genet 2008;9:255-266.
15. McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
16. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778.
17. Acton RT, Snively BM, Barton JC, et al. A genome-wide linkage scan for iron phenotype quantitative trait loci: The HEIRS Family Study. Clin Genet 2007;71:518-529.
18. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:251-252.
19. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
20. Barton JC, Lafreniere SA, Leiendecker-Foster C, et al. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS study participants. Am J Hematol 2009;84:710-714.
21. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999;64:1056-1062; Erratum, Am J Hum Genet 1999;64:491.
22. Acton RT, Barton JC, Snively BM, et al. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis 2006;16:815-821.
23. Andriopoulos B, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009;41:482-487.
24. Camaschella C. BMP6 orchestrates iron metabolism. Nat Genet 2009;41:386-388.
25. Meynard D, Kautz L, Darnaud V, et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009;41:478-481.
26. Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
27. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
28. Fernandes A, Preza GC, Phung Y, et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009;114:437-443.
29. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006;281:28494-28498.
30. Steiner M, Ocran K, Genschel J, et al. A homozygous HFE gene splice site mutation (IVS511 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology 2002;122:789-795.
31. Steiner M, Leiendecker-Foster C, McLaren GD, et al. Hemochromatosis (HFE) gene splice site mutation IVS511 G/A in North American Vietnamese with and without phenotypic evidence of iron overload. Transl Res 2007;149:92-95.
32. Lok CY, Merryweather-Clarke AT, Viprakasit V, et al. Iron overload in the Asian community. Blood 2009;114:20-25.
33. Lazarescu A, Snively BM, Adams PC. Phenotype variation in C282Y homozygotes for the hemochromatosis gene. Clin Gastroenterol Hepatol 2005;3:1043-1046.
34. Njajou OT, Alizadeh BZ, Aulchenko Y, et al. Heritability of serum iron, ferritin and transferrin saturation in a genetically isolated population, the Erasmus Rucphen Family (ERF) Study. Hum Hered 2006;61:222-228.
35. Milet J, Dehais V, Bourgain C, et al. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am J Hum Genet 2007;81:799-807.
36. Benyamin B, McRae AF, Zhu G, et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet 2009;84:60-65.
37. Whitfield JB, Cullen LM, Jazwinska EC, et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-1258.
38. Whiting PW, Fletcher LM, Dixon JK, et al. Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: Implications for family screening. J Hepatol 2002;37:309-314.